When someone has their first psychotic episode, every week matters. New research shows that shorter time without treatment is linked to better recovery in first-episode schizophrenia. This finding can help families and doctors act faster.
Schizophrenia is a serious mental illness that affects thinking, emotions, and behavior. It often starts in late teens or early adulthood. About 1 in 100 people live with it worldwide. First-episode schizophrenia refers to the first time a person has clear psychotic symptoms, such as hearing voices or having strong false beliefs.
The key measure here is duration of untreated psychosis, or DUP. This is the time from when symptoms first appear to when treatment begins. Many families do not know what is happening at first. They may think it is stress, a phase, or something else. This delay is common and can be hard to avoid.
Current care often focuses on starting medication and therapy once someone reaches a clinic. But what if the clock starts ticking earlier? What if the length of that delay shapes how well someone improves during their first hospital stay? That is the question this study asks.
But here is the twist. Past research has been mixed. Some studies show that longer DUP leads to worse outcomes. Others find no clear link. This study uses careful methods to test whether DUP still matters when other factors are controlled.
Think of DUP like a traffic jam on the road to recovery. The longer you sit in that jam, the harder it is to make up time later. Medication and therapy are the cars that move you forward. But if the jam lasts too long, the whole trip takes longer and feels rougher.
In this study, doctors looked at 99 patients with first-episode schizophrenia who were admitted to a hospital in China between 2015 and 2019. They measured DUP as short (26 weeks or less) or long (more than 26 weeks). They tracked symptom change using a standard tool called the Brief Psychiatric Rating Scale, or BPRS. This scale scores symptoms like anxiety, depression, and unusual thoughts. A lower score means fewer symptoms.
The team used a method called propensity score matching to make the two groups more similar at the start. This helps reduce bias. They then used a Bayesian model to adjust for other factors, such as baseline symptom severity. Subgroup analyses looked at whether DUP mattered more for certain patients.
In the unmatched group, patients with short DUP had greater symptom improvement than those with long DUP. The average difference was about 7 points on the BPRS. After matching, the difference was even larger, about 11.5 points. That is a meaningful change in how someone feels and functions.
The Bayesian model confirmed the pattern. Long DUP was linked to less improvement, even after adjusting for other factors. The model also showed that people with more severe symptoms at baseline tended to improve more. That makes sense because there is more room to improve. But the DUP effect remained clear.
Subgroup analyses suggested the link was stronger among patients with higher baseline symptom severity. In other words, for people who were quite ill at admission, shorter DUP mattered even more. This finding adds nuance. It suggests that early care may be especially important for those who are struggling the most.
This does not mean that treatment is available immediately everywhere.
Experts in the field have long argued that DUP is a modifiable risk factor. This study adds weight to that view. It supports using DUP as a practical indicator in clinical settings. Hospitals and clinics can track DUP to understand who may need more intensive support.
What does this mean for you or your loved one? If someone shows signs of psychosis, seeking help early is important. Talk to a primary care doctor, a mental health clinic, or a hospital. Ask about DUP and how it might affect recovery. Early detection can lead to faster treatment and better outcomes.
This study has some limits. It was done at one hospital, and the sample size was small. It focused on short-term outcomes during hospitalization. It did not follow people after discharge. The findings may not apply to all settings or populations.
What happens next? Researchers will need larger, multi-site studies to confirm these results. They will also look at longer-term outcomes, such as relapse rates and quality of life. Health systems can use these insights to improve early detection programs and reduce DUP.
